Loading data
NOVTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 980.6 m USD | 949.25 m USD | 881.66 m USD | 860.9 m USD | 706.79 m USD |
| Cost of revenue | 545.32 m USD | 527.7 m USD | 481.77 m USD | 482.43 m USD | 406.47 m USD |
| Gross profit | 435.28 m USD | 421.55 m USD | 399.9 m USD | 378.47 m USD | 300.33 m USD |
| Research and development expense | 95.48 m USD | 95.52 m USD | 91.68 m USD | 85.77 m USD | 72.52 m USD |
| Selling, general and administrative expense | 195.66 m USD | 175.94 m USD | 164.46 m USD | 158.9 m USD | 129.16 m USD |
| Operating profit | 94.01 m USD | 110.58 m USD | 110.5 m USD | 103.08 m USD | 64.05 m USD |
| Profit before tax | 69.64 m USD | 79.07 m USD | 83.75 m USD | 87.16 m USD | 56.17 m USD |
| Income tax expense | 15.81 m USD | 14.98 m USD | 10.87 m USD | 13.11 m USD | 5.84 m USD |
| Net income (reported basis) | 53.83 m USD | 64.09 m USD | 72.88 m USD | 74.05 m USD | 50.33 m USD |
| Basic earnings per share | 1.47 USD/share | 1.78 USD/share | 2.03 USD/share | 2.08 USD/share | 1.42 USD/share |
| Diluted earnings per share | 1.47 USD/share | 1.77 USD/share | 2.02 USD/share | 2.06 USD/share | 1.41 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.